AstraZeneca Pharma India moves Delhi High Court against NPPA demand notice

The notice of demand alleges that the company has overcharged about Rs 157.38 crore during the period from March 8, 2019 to January 31, 2021 in respect of Tagrisso (Osimertinib) 80 mg tablets.

from Markets-Economic Times https://ift.tt/3y9o2wO